MAGE-A1, a member of the melanoma-associated antigen (MAGE) family, plays a pivotal role in various cellular processes, particularly in the context of cancer. In healthy tissues, the MAGE-A1 gene is typically dormant or exhibits minimal activity. However, its activation is associated with malignant transformation, and aberrant expression is observed in a variety of cancer types. The MAGE-A1 protein itself has been implicated in modulating cell cycle progression, apoptosis, and immune responses, suggesting its involvement in critical pathways that contribute to tumorigenesis. MAGE-A1 activators represent a distinct chemical class with the unique ability to influence the expression of the MAGE-A1 gene. These activators function by interacting with the regulatory elements of the MAGE-A1 gene, initiating a cascade of events that culminate in enhanced transcription. This augmented transcription process leads to increased production of the MAGE-A1 protein, thereby promoting its cellular functions. The activation of the MAGE-A1 gene is a subject of significant interest in molecular biology, providing a window into the intricate mechanisms of gene regulation. Understanding the intricacies of MAGE-A1 activation not only sheds light on cancer-specific processes but also contributes to a broader comprehension of genetic and cellular dynamics. This knowledge has far-reaching implications beyond the scope of cancer research, offering insights into fundamental biological principles.
As scientists delve into the complexities of MAGE-A1 activators, their investigations hold the promise of uncovering critical discoveries that transcend disciplinary boundaries. Exploring the ramifications of MAGE-A1 activation can yield transformative insights, enriching our understanding of genetic and cellular processes. By unlocking the secrets of MAGE-A1 activation, researchers aim to broaden the horizon of knowledge in molecular biology, paving the way for innovative applications across diverse scientific disciplines.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
This short-chain fatty acid is also a histone deacetylase inhibitor, which can induce hyperacetylation of histones and influence gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This cytidine analog is involved in DNA demethylation and can activate the expression of tumor antigen genes like MAGE-A1. | ||||||
Temozolomide | 85622-93-1 | sc-203292 sc-203292A | 25 mg 100 mg | $89.00 $250.00 | 32 | |
An alkylating agent that can cause DNA damage, leading to stress responses that might upregulate antigens including MAGE-A1. | ||||||
Cobalt(II) chloride | 7646-79-9 | sc-252623 sc-252623A | 5 g 100 g | $63.00 $173.00 | 7 | |
It mimics hypoxic conditions, which can lead to HIF-1 activation and may upregulate the expression of genes like MAGE-A1. | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $75.00 $163.00 $622.00 $4906.00 $32140.00 | 43 | |
A derivative of butyric acid, this compound is a histone deacetylase inhibitor that can alter epigenetic marks and influence gene expression. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
It is a natural compound acting as an HDAC inhibitor, which might enhance the expression of certain genes including MAGE-A1. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $115.00 $337.00 | 3 | |
This naturally occurring pentacyclic triterpenoid has been shown to modulate multiple signaling pathways, possibly affecting MAGE-A1 expression. | ||||||